NASDAQ: ATHE
Alterity Therapeutics Ltd Stock Ownership - Who owns Alterity Therapeutics?

Insider buying vs selling

Have Alterity Therapeutics Ltd insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when ATHE insiders and whales buy or sell their stock.

ATHE Shareholders

What type of owners hold Alterity Therapeutics Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Morgan Stanley0.00%44,401$154.07kInstitution
Point72 Asset Management LP0.00%32,627$113.22kInstitution
Hb Wealth Management LLC0.00%31,883$110.63kInstitution
Bnp Paribas Financial Markets0.00%8,790$30.50kInstitution
Twin Lakes Capital Management LLC0.00%5,925$20.56kInstitution
Ubs Group Ag0.00%384$1.33kInstitution
Osaic Holdings Inc0.00%81$281.07Institution
Blue Trust Inc0.00%40$138.80Institution
Sugarloaf Wealth Management LLC0.00%33$114.51Institution
Northwestern Mutual Wealth Management Co0.00%16$55.52Institution

1 of 2

ATHE vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ATHE0.00%0.00%
SPRO28.05%63.87%Net SellingNet Selling
DYAI8.92%91.08%Net BuyingNet Buying
ANTX37.29%62.71%Net Selling
SRZN11.49%88.51%Net BuyingNet Buying

Alterity Therapeutics Stock Ownership FAQ

Who owns Alterity Therapeutics?

Alterity Therapeutics (NASDAQ: ATHE) is owned by 0.00% institutional shareholders, 0.00% Alterity Therapeutics insiders, and 100.00% retail investors. Morgan Stanley is the largest individual Alterity Therapeutics shareholder, owning 44,401.00 shares representing 0.00% of the company. Morgan Stanley's Alterity Therapeutics shares are currently valued at $153.63k.

If you're new to stock investing, here's how to buy Alterity Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.